https://scholars.lib.ntu.edu.tw/handle/123456789/523223
標題: | Assessment of menopause-induced myocardial changes by integrated backscatter during inotropic stimulation and atropine injection | 作者: | YI-LWUN HO Lin, Lung-Chun MEN-LUH YEN CHAU-CHUNG WU SONG-NAN CHOW Huang P.-J. |
公開日期: | 2002 | 卷: | 28 | 期: | 7 | 起(迄)頁: | 889-895 | 來源出版物: | Ultrasound in Medicine and Biology | 摘要: | Estradiol has been considered as an L-type calcium channel blocker in animal studies. The concentration of estradiol decreases after menopause. Therefore, we hypothesized that human myocardial functional changes developed after menopause, and those changes could be evaluated through the use of cyclic variation of integrated backscatter (CVIBS). A total of 16 patients with menopause (native and surgical menopause), follicular stimulating hormone > 40 IU/L and estradiol < 20 pg/mL underwent dobutamine stress IBS examination (study group). Another 12 women with normal menstruation, follicular stimulating hormone < 40 IU/L and estradiol > 20 pg/mL were enrolled as a control group. All patients had a low likelihood of coronary artery disease and negative results of dobutamine stress echocardiography and 201thallium scintigraphy. To avoid the phenomenon of anisotropy, the amplitude and phase of IBS were acquired only in the midanteroseptal segment from the parasternal short axis view. The baseline amplitudes of CVIBS differed between the control and study groups (5.9 ± 1.2 dB vs. 8.1 ± 2.1 dB; p = 0.007). The amplitudes during low-dose (20 μg/kg-min) and peak-dose (40 μg/kg-min) dobutamine infusion were also different between these 2 groups (5.7 ± 0.9 dB vs. 8.4 ± 1.7 dB; p < 0.001; 6.0 ± 1.0 dB vs. 7.7 ± 2.4 dB; p = 0.026). However, there were no significant differences in amplitudes between these two groups after atropine injection (control group 4.5 ± 1.2 dB, study group 5.3 ± 1.0 dB; p = NS). No significant differences of phase were found either at baseline or under dobutamine infusion between the two groups. Multivariate linear regression analysis showed that only menopause status associated significantly with the amplitudes at different doses of dobutamine infusion (p < 0.05). In conclusion, human myocardial functional changes are observed by CVIBS after menopause. Postmenopausal women have higher values of amplitude than premenopausal women. These phenomena persist during low and peak doses of dobutamine infusion, but are abolished by atropine injection. ? 2002 World Federation for Ultrasound in Medicine & Biology. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036657940&doi=10.1016%2fS0301-5629%2802%2900529-X&partnerID=40&md5=3bd90b8068d15f29d5319f71a5cec471 https://scholars.lib.ntu.edu.tw/handle/123456789/523223 |
ISSN: | 0301-5629 | DOI: | 10.1016/S0301-5629(02)00529-X | SDG/關鍵字: | Backscattering; Diseases; Echocardiography; Patient treatment; Channel blockers; Ultrasonics; atropine; dobutamine; estradiol; follitropin; high density lipoprotein; low density lipoprotein; thallium 201; adult; anisotropy; article; clinical article; coronary artery disease; electrocardiography; female; heart function; human; infusion; inotropism; linear regression analysis; menstruation; postmenopause; premenopause; priority journal; scintigraphy; stress echocardiography; Adult; Atropine; Cardiotonic Agents; Dobutamine; Echocardiography; Female; Humans; Menopause; Middle Aged; Myocardium; Observer Variation; Parasympatholytics |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。